CRM vs NICE: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: NICE is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CRM and NICE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CRM and NICE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Salesforce is the leading provider of cloud-based customer relationship management (CRM) software, helping companies manage sales, customer service, marketing, e-commerce, and analytics. Its core products include Sales Cloud, Service Cloud, Marketing Cloud, and Commerce Cloud, plus a broad platform for building custom applications. Through major acquisitions it also owns Slack (workplace collaboration), Tableau (data visualization and analytics), and MuleSoft (data integration), and it has pushed aggressively into artificial intelligence with its Einstein features and, more recently, Agentforce, a platform for deploying AI agents that automate sales, service, and other workflows. Salesforce makes money primarily through recurring subscription and support revenue, billed per user, giving it highly predictable, sticky software revenue at large scale. It is one of the largest enterprise software companies in the world, headquartered in San Francisco, and serves businesses of all sizes across virtually every industry globally.

Full CRM guide

NICE Ltd is an Israeli-headquartered enterprise software company listed on Nasdaq and the Tel Aviv Stock Exchange. Its larger Customer Engagement segment offers CXone Mpower, a cloud contact center platform (CCaaS) that handles routing, digital channels, workforce management, quality and analytics for large enterprises, increasingly bundled with AI agents and self-service automation. Its smaller Financial Crime and Compliance segment, NICE Actimize, provides anti-money-laundering, fraud detection and trade surveillance software to banks and financial institutions. Roughly three quarters of revenue is now recurring cloud revenue, and the company also retains a legacy on-premise and public safety business.

Full NICE guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CRM drivers: Agentforce and AI monetization; Dominant CRM franchise and data moat.
• NICE drivers: Cloud migration and CXone Mpower; AI monetization and the Cognigy acquisition.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Salesforce's subscription growth has decelerated from its hyper-growth past into the low-to-mid teens or lower, and the durability of reacceleration from AI is unproven. For NICE, the central risk is structural: generative AI could compress the number of human agents enterprises staff, and NICE's contact center economics have historically scaled with seats.

Pick CRM if you believe its drivers more; NICE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CRM and NICE guides.

CRM. Salesforce trades at a software premium that reflects its CRM market leadership, sticky recurring revenue, and dramatically improved margins and free cash flow. The valuation now balances a maturing growth profile against optionality from AI (Agentforce and Data Cloud). The market is essentially weighing whether AI can reaccelerate growth enough to justify the multiple as core seat growth slows.

NICE. NICE trades at roughly single-digit earnings multiples and a mid-single-digit EV/EBITDA, unusual for a software company still compounding cloud revenue in the mid teens. That multiple embeds a market view that AI erodes the seat-based model faster than AI products replace it. The counterweight is a net cash balance sheet, about ~$1 billion of remaining repurchase capacity, and an Actimize sale process valued near ~$2.5 billion against a ~$5.1 billion market cap.

Headline figures (approximate, early 2026): CRM shows revenue (ttm) ~$38 billion, operating margin (gaap) ~20%; adjusted margins meaningfully higher, revenue growth high-single-digit to low-teens, decelerated from past, dividend yield ~0.5-0.7% (recently initiated); NICE shows revenue (ttm) ~$3.0B, q1 2026 revenue ~$769M (+9.8% YoY), cloud revenue (q1 2026) ~$603M (+14.6% YoY), 2026 revenue guidance ~$3.17B-$3.19B (~8% growth).

CRM and NICE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CRM and NICE exposure against your real portfolio. It is not an investment adviser.